Biblio
Export 14 results:
Author Title Type [ Year] Filters: Author is Visser, Pieter Jelle [Clear All Filters]
“Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.”, J Alzheimers Dis, vol. 64, no. s1, pp. S213-S227, 2018.
, , “Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1387-1395, 2017.
, “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
, “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
, “Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1417-1427, 2017.
, “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
, “Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1119-1128, 2017.
, “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
,